Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 7.
doi: 10.1007/7854_2024_556. Online ahead of print.

Canonical Cannabinoid Receptors

Beth Ehrlich  1 , Monica Patel  1 , Xiaoxi Zheng  1   2 , Michelle Glass  3   4
Affiliations

Canonical Cannabinoid Receptors

Beth Ehrlich et al. Curr Top Behav Neurosci. .

Abstract

This chapter will review the basic pharmacology of the canonical cannabinoid receptors. The endocannabinoid system is a complex signalling network involved in a wide range of physiological processes, including pain modulation, appetite regulation, and synaptic plasticity. The canonical cannabinoid receptors, CB1 and CB2, are central in orchestrating this system. CB1 is highly enriched in the central nervous system (CNS), where it plays a crucial role in modulating neurotransmitter release and synaptic plasticity. In contrast, CB2 is predominantly expressed in peripheral tissues and immune cells, participating in anti-inflammatory processes. Here, we focus on cannabinoid receptor distribution, intracellular signalling, and receptor regulation. We describe the intracellular signalling pathways activated by CB1, including the modulation of ion channels, second messengers, and protein kinases. Overall, this chapter provides an overview of the canonical cannabinoid receptors and their role in the regulation of neuronal signalling and plasticity, highlighting the molecular and cellular mechanisms underlying their effects in the CNS.

Keywords: 2-Arachidonyl glycerol; Anandamide; CB1; CB2; Cannabinoid; ERK; Endocannabinoid; G protein; Protein kinase; Retrograde neurotransmitter; Signalling; cAMP.

PubMed Disclaimer

References

    1. Andó RD, Bíró J, Csölle C, Ledent C, Sperlágh B (2012) The inhibitory action of exo- and endocannabinoids on [3H]GABA release are mediated by both CB1 and CB2 receptors in the mouse hippocampus. https://doi.org/10.1016/J.NEUINT.2011.11.012 - DOI
    1. Ashton JC, Zheng Y, Darlington CL, Baek J-H, Smith PF (2014) Cannabinoid CB2 receptor immunolabelling in the healthy brain – still a live possibility. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/S00210-013-0948-Y
    1. Atwood BK, Mackie K (2010) CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol. https://doi.org/10.1111/J.1476-5381.2010.00729.X
    1. Baek J-H, Darlington CL, Smith PF, Ashton JC (2013) Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB2 receptor. J Neurosci Methods. https://doi.org/10.1016/J.JNEUMETH.2013.03.021
    1. Barnier JV, Papin C, Eychène A, Lecoq O, Calothy G (1995) The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J Biol Chem 270(40):23381–23389. https://doi.org/10.1074/jbc.270.40.23381 - DOI

LinkOut - more resources